Joseph M McCune

Title: Joseph M McCune: Innovator in CD47 Targeted Therapies

Introduction

Joseph M McCune is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the development of therapies targeting CD47 for the treatment of infectious diseases. With a total of 16 patents to his name, McCune's work has the potential to impact the way infectious diseases are treated.

Latest Patents

Among his latest patents, McCune has developed methods for treating subjects with intracellular pathogen infections. These methods involve administering an agent that reduces the binding of CD47 on an infected cell to SIRPα on a host phagocytic cell. This innovative approach aims to increase the phagocytosis of infected cells, thereby enhancing the body's ability to combat infections.

Career Highlights

Throughout his career, McCune has worked with notable organizations such as Systemix, Inc. and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in targeted therapies.

Collaborations

Some of McCune's notable coworkers include Hideto Kaneshima and Reiko Namikawa. Their collaborative efforts have contributed to the advancement of research in the area of infectious disease treatment.

Conclusion

Joseph M McCune is a distinguished inventor whose work in CD47 targeted therapies is paving the way for new treatment options for infectious diseases. His innovative methods and collaborations highlight the importance of research in improving healthcare outcomes.